Both in Biotechnology
Jasper Therapeutics vs BioCardia
Over the past year JSPR returned −71.8% and BCDA returned −31.3%; their daily moves had a correlation of -0.04.
JSPR −71.8% BCDA −31.3%Growth of $1, one year, split-adjusted
| Metric | JSPR | BCDA |
|---|---|---|
| Price | $0.5111 | $0.9131 |
| Market cap | $17.0M | $13.8M |
| Today | +6.48% | −0.92% |
| 1 month | −8.7% | −13.9% |
| 6 months | −46.0% | −17.7% |
| Year to date | −72.1% | −27.0% |
| 1 year | −75.7% | −34.3% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.3M | $4.1M |
| Dividend yield | — | — |
| Volatility (60d) | 75.7% | 68.9% |
| Short % of float | 22.6% | 6.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).